semaglutide and cardiovascular Beyond obesity: Novo's SELECT re-defines risk management Heart disease: Semaglutide may reduce

GLP-1 receptor agonists and mental health

The palpitations associated with GLP-1 therapy reflect temporary autonomic nervous system adaptation, not cardiac tissue injury

The PlexusDx Precision Peptide Genetic Test identifies genetic variants in GLP1R, FTO, MC4R, and GIPR pathways that influence hunger, satiety, and metabolic rate

Mistake 4: adding too much or too little water Adding more water than intended dilutes the solution beyond your planned concentration

Both formulations undergo quality testing, though compounding allows for flexible dosing without fixed pen increments

Gastrointestinal side effects like nausea tend to be dose-dependent rather than time-dependent, though a few patients experience less nausea when injecting before bed and sleeping through the medication's initial adjustment phase